Navigation Links
Drug prevents bone loss side effects of breast cancer medication
Date:10/9/2011

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.

Drugs called aromatase inhibitors stop the production of estrogen in postmenopausal women and therefore make less estrogen available to stimulate the growth of certain breast cancer cells. Many postmenopausal women with breast cancer are routinely treated for several years with these potentially life-saving drugs, but the agents can cause bone loss and fractures.

Adam Brufsky, MD, PhD, of the University of Pittsburgh Cancer Institute, and his colleagues conducted a study to see if the bone drug zoledronic acid could prevent and treat bone loss in postmenopausal breast cancer patients. In their five-year study, called Z-FAST, 602 postmenopausal women with early breast cancer who were receiving the aromatase inhibitor letrozole were randomized to receive zoledronic acid simultaneously with letrozole or only after bone loss or fractures occurred.

The investigators observed significant and progressive increases in bone density throughout the five years of the study in women who initiated zoledronic acid at the start; in contrast, significant decreases in bone density occurred when zoledronic acid administration was delayed until bone loss was apparent. Over time, though, the rate of bone density decline in the delayed group slowed, most likely because more delayed patients received zoledronic acid by the end of the study. These findings indicate that bone density is maintained more effectively with upfront zoledronic acid, but bone loss is likely reversible so that initiating zoledronic acid, even after bone loss has developed, is beneficial.

"This study shows that bone loss from aromatase inhibitors can be prevented long term with a safe and effective drug that prevents osteoporosis," said Dr. Brufsky. Zoledronic acid is currently approved by the U.S. Food and Drug Administration for conditions including osteoporosis and bone complications of cancer.


'/>"/>

Contact: Jennifer Beal
healthnews@wiley.com
44-124-377-0633
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Knockout of protein prevents colon tumor formation in mice
2. Marijuana administration after a traumatic experience prevents post-traumatic stress symptoms
3. Adding a stent during minimally invasive surgery to repair aneurysms prevents recurrence
4. Tai Chi Prevents Falls, Boosts Mental Health in Seniors: Study
5. UNC-led study shows early treatment with antiretroviral therapy prevents HIV transmission
6. Tobacco-derived compound prevents memory loss in Alzheimers disease mice
7. Early infusion of donor T cells prevents graft versus host disease in blood cancer patients
8. Tomatoes found to contain nutrient which prevents vascular diseases
9. Finnish researchers find a compound that prevents the growth of prostate cancer cells
10. Researchers establish new rule to predict risk of stroke, death from surgery that prevents it
11. New discovery prevents symptoms of rare genetic disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... ... device compliance and commercialization, has just announced two more sessions of its “From ... engineering into risk management activities. Led by David Cronin, Cognition’s CEO, the half-hour ...
(Date:7/18/2017)... ... July 18, 2017 , ... The results of an international clinical trial, led in ... for a severe type of muscular dystrophy holds promise for a subgroup of patients. , ... McDonald and colleagues at 53 study sites in 18 countries describe the clinical benefit ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, ... "Due to menopause, I have frequent hot flashes, and I suffer from anxiety and ... way to keep cool while out and about." INSTA-FAN meets that need. , This ...
(Date:7/18/2017)... ... July 18, 2017 , ... Heritage Woods of Benton, a ... to 12:30 p.m. on Aug. 15. , The community, which is located at 1305 ... Medicaid, who need some help to maintain their independence. , The lunch menu will ...
(Date:7/18/2017)... ... 18, 2017 , ... FCPX LUT Berlin for Final Cut Pro X gives ... includes 60 different color-grade presets, giving FCPX users numerous options for adding different color ... each subject, plus much more. FCPX LUT Berlin is designed for any skill-level, from ...
Breaking Medicine News(10 mins):
(Date:6/27/2017)... Jun 27, 2017   NuEyes (NuEyes Technologies Inc.) ... to fuel its growth in helping the legally blind live ... Design Group), the leading developer of augmented, virtual and mixed ... The undisclosed funding amount was provided by strategic ... Angel, with offices in Abu Dhabi , ...
(Date:6/19/2017)... 19, 2017  Researchers from DRUGSCAN ® and ... host a live, complimentary webinar titled, "Untangling methods to ... the real world" on Wednesday June 28, 2017 from ... This webinar will feature interviews with recreational and dependent ... manipulation techniques abusers use to prepare opioid tablets for ...
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
Breaking Medicine Technology: